1. German lipid clinic experience with adherence to PCSK-9-inhibitor therapy. (December 2020) Authors: Waldmann, E.; Altenhofer, J.; Henze, K.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipoprotein(a) concentrations and apolipoprotein-E isoforms. Issue 1 (July 2015) Authors: Waldmann, E.; Stark, R.G.; Altenhofer, J.; Henze, K.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pcsk9-Inhibition In Routine Clinical Practice: Real World Data From Germany. (August 2019) Authors: Waldmann, E.; Altenhofer, J.; Henze, K.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗